Accretion Nutraveda Board Approves Business Diversification and Higher Borrowing Limits
Accretion Nutraveda Ltd 路 Others (Uncategorized) 路 01 Sept 2026, 6:13 pm
Accretion Nutraveda Board Approves Business Diversification and Higher Borrowing Limits Accretion Nutraveda's board, on 1st Sep'26, approved altering its Memorandum of Association to diversify business activities. This includes manufacturing and trading in pharmaceuticals, nutraceuticals, medical devices, and operating healthcare facilities like hospitals and diagnostic centres. The board also approved proposals to increase borrowing limits, enhance limits for creating security on company assets, and grant loans, guarantees, and investments beyond prescribed thresholds. These approvals are subject to shareholder consent via a postal ballot.
Original exchange filing (PDF)
More announcements from Accretion Nutraveda Ltd
- Intimation wrt change in Corporate Office address of Kfin Technologies Limited (RTA) with effective from 01st December, 2026 路 16 Nov 2026
- Please find enclosed herewith Investor/Analysts Presentation for the Half Year ended on 30th September, 2026 路 03 Nov 2026
- Intimation regarding update of corporate Identification Number (CIN) of the Company. 路 03 Nov 2026
- Accretion Nutraveda Limited inform the stock exchange regarding press release dated 31st October, 2026 路 01 Nov 2026
- Please find enclosed herewith Outcome of the Board Meeting dated 31st October, 2026 路 01 Nov 2026
- Accretion Nutraveda Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2026 ,inter alia, to consider and approve Please find enclosed herewith .... 路 31 Oct 2026
- Please find enclosed herewith intimation w.r.t Amendments to Memorandum of Association 路 11 Oct 2026
- Please find enclosed herewith with respect to Board Meeting update 路 02 Sept 2026
